Print Page   |   Contact Us   |   Sign In   |   Join
News and Press: Member Organization News

Stryker Wins FDA Nod for Cementless Mako Total Knee System

Wednesday, October 18, 2017   (0 Comments)
Share |



Stryker (NYSE:SYK) said today it won FDA 510(k) clearance for its cementless Mako total knee system with Triathlon Tritanium.

The Kalamazoo, Mich.-based company touted the Triathlon Titanium as combining kinematics from its Triathlon knee with highly porous biologic fixation technology. The system features the company’s Tritanium tibial baseplate and metal-backed patella components as well, the company said.

Stryker said that cementless procedures are increasing in popularity, and the newly cleared platform expands the robotics offerings for orthopedic surgeons seeking an alternative to bone cement.

“With the rise in demand for cementless knee technology, we believe this new offering can have a positive impact on procedural efficiency and patient outcomes. We’re excited to continue to lead in robotic technology and combine two of our most advanced and differentiated products to provide surgeons with the ability to transform orthopaedic surgery,” Stryker joint replacement division prez Stuart Simpson said in a press release.

Late last week, Stryker won a $3.4 million tax-rebate incentive from the state of Utah to expand its neurotechnology training and manufacturing center in Salt Lake City, according to a Salt Lake Tribune report.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal